Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
<p>Abstract</p> <p>Background</p> <p>HMG-CoA reductase inhibitors (statins) are commonly used in medicine to control blood lipid disorder. Large clinical trials have demonstrated that statins greatly reduces cardiovascular-related morbidity and mortality in patients wit...
Main Authors: | Jobin Jean, Bergeron Jean, Gagné Claude, Noël Martin, Poirier Paul |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-05-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/3/1/7 |
Similar Items
-
Pleiotropic effects of the HMG-CoA reductase inhibitors
by: Mihos CG, et al.
Published: (2011-04-01) -
The discovery and development of HMG-CoA reductase inhibitors.
by: A Endo
Published: (1992-11-01) -
Butyrate and HMG-CoA reductase inhibitors in ulcerative colitis
by: McKay, Damian
Published: (2010) -
HMG-CoA reductase kinase: measurement of activity by methods that preclude interference by inhibitors of HMG-CoA reductase activity or by mevalonate kinase.
by: H J Harwood, Jr, et al.
Published: (1982-07-01) -
MTD–CoMSIA modelling of HMG-CoA reductase inhibitors
by: DANIEL M. DUDA-SEIMAN, et al.
Published: (2011-01-01)